BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 32077332)

  • 1. Transcription factor-mediated regulation of the BCRP/
    Gorczyca L; Aleksunes LM
    Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):239-253. PubMed ID: 32077332
    [No Abstract]   [Full Text] [Related]  

  • 2. An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.
    Han LW; Gao C; Mao Q
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):817-829. PubMed ID: 30010462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transcriptional regulation of breast cancer resistance protein].
    Wu XG; Peng SB; Huang Q
    Yi Chuan; 2012 Dec; 34(12):1529-36. PubMed ID: 23262099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids modulate multidrug resistance transporters in the first trimester human placenta.
    Lye P; Bloise E; Nadeem L; Gibb W; Lye SJ; Matthews SG
    J Cell Mol Med; 2018 Jul; 22(7):3652-3660. PubMed ID: 29691980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
    Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
    Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual Regulation of the Breast Cancer Resistance Protein/
    Bircsak KM; Moscovitz JE; Wen X; Archer F; Yuen PYS; Mohammed M; Memon N; Weinberger BI; Saba LM; Vetrano AM; Aleksunes LM
    Drug Metab Dispos; 2018 May; 46(5):619-627. PubMed ID: 29386232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prostaglandin E2 on multidrug resistance transporters in human placental cells.
    Mason CW; Lee GT; Dong Y; Zhou H; He L; Weiner CP
    Drug Metab Dispos; 2014 Dec; 42(12):2077-86. PubMed ID: 25261564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetoprotective activity of breast cancer resistance protein (BCRP, ABCG2): expression and function throughout pregnancy.
    Hahnova-Cygalova L; Ceckova M; Staud F
    Drug Metab Rev; 2011 Feb; 43(1):53-68. PubMed ID: 20854129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter.
    Xu Z; Li M; Lu W; Wang L; Zhang Y
    Poult Sci; 2023 Jan; 102(1):102278. PubMed ID: 36402040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional expression of the BCRP/ABCG2 transporter in term human placentas.
    Memon N; Bircsak KM; Archer F; Gibson CJ; Ohman-Strickland P; Weinberger BI; Parast MM; Vetrano AM; Aleksunes LM
    Reprod Toxicol; 2014 Jan; 43():72-77. PubMed ID: 24269555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Resistance Protein: A Potential Therapeutic Target for Cancer.
    Mehendale-Munj S; Sawant S
    Curr Drug Targets; 2021; 22(4):420-428. PubMed ID: 33243119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
    Baxter DE; Kim B; Hanby AM; Verghese ET; Sims AH; Hughes TA
    Clin Breast Cancer; 2018 Dec; 18(6):481-488. PubMed ID: 30055962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
    Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
    Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCRP/ABCG2 in the placenta: expression, function and regulation.
    Mao Q
    Pharm Res; 2008 Jun; 25(6):1244-55. PubMed ID: 18202831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
    Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
    J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCG2/BCRP: variants, transporter interaction profile of substrates and inhibitors.
    Safar Z; Kis E; Erdo F; Zolnerciks JK; Krajcsi P
    Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):313-328. PubMed ID: 30856014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.